ACTIVE

APOTHEEK DERIDDER

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

108,3 k €

-20.9% YoY

Gross margin

309,1 k €

+4.1% YoY

Equity

277,7 k €

+26.6% YoY

Workforce

2,3 ETP

+9.5% YoY

What does APOTHEEK DERIDDER do?

APOTHEEK DERIDDER is a Private limited company incorporated in 2004. Its registered office is in Halle. It employs on average 2,3 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0867.660.149

Incorporation

06/10/2004

Legal form

Private limited company

Registered office

Nachtegaalstraat 35
1501 Halle · FlandreSee on map

Contributed capital

18 550,00 €

Latest accounts

31/12/2025

Average workforce

2,3 ETP

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	309,1 k €	+4.1%	297 k €	+12.4%	264,2 k €	+12.8%	234,2 k €	+8.3%	216,2 k €	+2.3%	211,3 k €	+3.7%	203,8 k €	+4.6%	194,9 k €	+34.5%	144,9 k €	+21.7%	119,1 k €	+24.1%	96 k €	-16.0%	114,3 k €	-40.7%	192,8 k €	-1.2%	195,2 k €	+18.5%	164,8 k €	+5.8%	155,8 k €	-15.6%	184,5 k €	+17.9%	156,5 k €	+15.4%	135,6 k €	+31.1%	103,4 k €
EBITDA	169,3 k €	-14.1%	197 k €	+17.6%	167,6 k €	+13.8%	147,2 k €	-0.6%	148,1 k €	+2.8%	144 k €	+33.3%	108,1 k €	+3.0%	104,9 k €	+91.3%	54,8 k €	+30.0%	42,2 k €	+1.4%	41,6 k €	-36.1%	65,1 k €	+16.0%	56,1 k €	-33.5%	84,3 k €	+78.0%	47,4 k €	-8.3%	51,6 k €	-42.3%	89,4 k €	+41.3%	63,3 k €	+46.6%	43,2 k €	+102%	21,3 k €
Operating result	134,1 k €	-17.7%	162,9 k €	+22.1%	133,4 k €	+18.0%	113,1 k €	+0.0%	113 k €	+4.5%	108,2 k €	+90.8%	56,7 k €	+7.1%	52,9 k €	+10784%	-495,3 €	-103%	16,6 k €	+5.3%	15,7 k €	-0.6%	15,8 k €	+1760%	851 €	-98.0%	41,6 k €	+734%	5 k €	-63.5%	13,7 k €	-72.6%	49,8 k €	+122%	22,5 k €	+305%	5,6 k €	+136%	-15,3 k €
Net result	108,3 k €	-20.9%	136,8 k €	+19.5%	114,5 k €	+22.6%	93,4 k €	-23.6%	122,2 k €	+33.9%	91,3 k €	+178%	32,8 k €	-2.8%	33,8 k €	+309%	-16,2 k €	-382%	5,7 k €	+62.1%	3,5 k €	+64.5%	2,1 k €	+116%	-13,1 k €	-157%	22,8 k €	+1177%	1,8 k €	-80.1%	9 k €	-73.5%	33,8 k €	+89.5%	17,9 k €	+549%	2,8 k €	+116%	-16,8 k €
Balance sheet
Equity	277,7 k €	+26.6%	219,4 k €	-0.1%	219,7 k €	+21.2%	181,2 k €	+24.3%	145,9 k €	+26.1%	115,7 k €	+5.7%	109,4 k €	+42.8%	76,6 k €	+78.8%	42,8 k €	-27.4%	59 k €	-54.0%	128,3 k €	+2.8%	124,7 k €	+1.8%	122,6 k €	-9.6%	135,6 k €	+20.2%	112,9 k €	+1.6%	111,1 k €	+8.8%	102,1 k €	+49.9%	68,1 k €	+35.5%	50,3 k €	+5.8%	47,5 k €
Total assets	488,5 k €	-10.3%	544,8 k €	+7.2%	508,1 k €	+7.5%	472,4 k €	-13.5%	546,2 k €	-11.0%	613,6 k €	-3.9%	638,8 k €	-2.9%	657,9 k €	-5.8%	698,7 k €	+43.6%	486,7 k €	-10.2%	541,8 k €	-7.7%	587 k €	-5.6%	621,8 k €	-1.7%	632,4 k €	+5.4%	600,2 k €	+31.2%	457,4 k €	-9.2%	503,9 k €	+12.6%	447,4 k €	+12.1%	398,9 k €	-17.5%	483,6 k €
Cash	167 k €	-28.1%	232,4 k €	+37.8%	168,6 k €	+40.0%	120,5 k €	-13.9%	140 k €	-8.9%	153,7 k €	+105%	75 k €	+60.6%	46,7 k €	-17.7%	56,8 k €	-53.3%	121,5 k €	-18.9%	149,8 k €	-9.8%	166 k €	+7.0%	155,2 k €	+29.5%	119,8 k €	+1.9%	117,5 k €	+61.8%	72,7 k €	-46.7%	136,3 k €	+131%	58,9 k €	+97.1%	29,9 k €	-48.7%	58,3 k €
Debts	209,3 k €	-35.4%	323,9 k €	+12.7%	287,4 k €	-1.1%	290,7 k €	-27.1%	398,6 k €	-19.5%	495,3 k €	-6.0%	526,9 k €	-9.4%	581,3 k €	-11.4%	655,9 k €	+53.3%	427,7 k €	+3.4%	413,5 k €	-10.5%	462,3 k €	-7.4%	499,2 k €	+0.5%	496,7 k €	+1.9%	487,3 k €	+40.7%	346,3 k €	-13.8%	401,8 k €	+5.9%	379,3 k €	+8.8%	348,7 k €	-20.0%	436 k €
Other
Workforce	2,3 ETP	+9.5%	2,1 ETP	+5.0%	2,0 ETP	0.0%	2,0 ETP	+11.1%	1,8 ETP	+63.6%	1,1 ETP	-42.1%	1,9 ETP	-5.0%	2,0 ETP	0.0%	2,0 ETP	+5.3%	1,9 ETP	+35.7%	1,4 ETP	-6.7%	1,5 ETP	+50.0%	1,0 ETP	0.0%	1,0 ETP	-28.6%	1,4 ETP	+16.7%	1,2 ETP	+50.0%	0,8 ETP	-20.0%	1,0 ETP	+25.0%	0,8 ETP	0.0%	0,8 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 9 ended

Active mandates

Farma Nachtegaal

Director · since 24 mars 2020 · 0738.916.207

Represented by Bram De Greef

Active

Ended mandates

Farma Nachtegaal

Director · since 24 mars 2020 · 0738.916.207

Represented by De GREEF BRAM

Ended

Farma Nachtegaal

Director · since 20 mars 2020 · 0738.916.207

Represented by Bram De Greef

Ended

ELS DERIDDER

Manager · since 15 septembre 2004

Ended

Daniel De Greef

Mandate

Ended

At this address

Other companies at this address

Company	CBE no.
Farma Nachtegaal● Active	0738.916.207

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	04/08/2026	01/08/2025	05/08/2024	21/07/2023	11/08/2022	19/08/2021
General meeting	16/06/2026	17/06/2025	18/06/2024	20/06/2023	21/06/2022	15/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

21 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	16/06/2026	04/08/2026	Dutch	PDF
Abridged model	31/12/2024	17/06/2025	01/08/2025	Dutch	PDF
Abridged model	31/12/2023	18/06/2024	05/08/2024	Dutch	PDF
Abridged model	31/12/2022	20/06/2023	21/07/2023	Dutch	PDF
Abridged model	31/12/2021	21/06/2022	11/08/2022	Dutch	PDF
Abridged model	31/12/2020	15/06/2021	19/08/2021	Dutch	PDF
Abridged modelCorrection	31/12/2019	16/06/2020	04/08/2020	Dutch	PDF
Abridged model	31/12/2019	16/06/2020	24/07/2020	Dutch	PDF
Abridged model	31/12/2018	18/06/2019	13/08/2019	Dutch	PDF
Abridged model	31/12/2017	19/06/2018	12/07/2018	Dutch	PDF
Abridged model	31/12/2016	20/06/2017	13/07/2017	Dutch	PDF
Abridged model	31/12/2015	21/06/2016	22/06/2016	Dutch	PDF
Abridged model	31/12/2014	16/06/2015	25/06/2015	Dutch	PDF
Abridged model	31/12/2013	18/06/2014	28/07/2014	Dutch	PDF
Abridged model	31/12/2012	19/06/2013	20/06/2013	Dutch	PDF
Abridged model	31/12/2011	19/06/2012	22/06/2012	Dutch	PDF
Abridged model	31/12/2010	21/06/2011	22/06/2011	Dutch	PDF
Abridged model	31/12/2009	14/05/2010	02/07/2010	Dutch	PDF
Abridged model	31/12/2008	16/06/2009	01/07/2009	Dutch	PDF
Abridged model	31/12/2007	17/06/2008	04/07/2008	Dutch	PDF
Abridged model	31/12/2006	19/06/2007	05/07/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 9 ended

Active mandates

Farma Nachtegaal

Director · since 24 mars 2020 · 0738.916.207

Represented by Bram De Greef

Active

Ended mandates

Farma Nachtegaal

Director · since 24 mars 2020 · 0738.916.207

Represented by De GREEF BRAM

Ended

Farma Nachtegaal

Director · since 20 mars 2020 · 0738.916.207

Represented by Bram De Greef

Ended

ELS DERIDDER

Manager · since 15 septembre 2004

Ended

Daniel De Greef

Mandate

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates26/03/2020
WIJZIGING RECHTSVORM - MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
PDF
Other24/01/2005
DIVERSEN
PDF
Other14/10/2004
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025108,3 k €↓
2024
Annual accounts 2024136,8 k €↑
2023
Annual accounts 2023114,5 k €↑
2022
Annual accounts 202293,4 k €↓
2021
Annual accounts 2021122,2 k €↑
2020
Annual accounts 202091,3 k €↑
2019
Annual accounts 201932,8 k €↓
2018
Annual accounts 201833,8 k €↑
2017
Annual accounts 2017-16,2 k €↓
2016
Annual accounts 20165,7 k €↑
2015
Annual accounts 20153,5 k €↑
2014
Annual accounts 20142,1 k €↑
2013
Annual accounts 2013-13,1 k €↓
2012
Annual accounts 201222,8 k €↑
2011
Annual accounts 20111,8 k €↓
2010
Annual accounts 20109 k €↓
2009
Annual accounts 200933,8 k €↑
2008
Annual accounts 200817,9 k €↑
2007
Annual accounts 20072,8 k €↑
2006
Annual accounts 2006-16,8 k €
06/10/2004
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

APOTHEEK DERIDDER

Overview

What does APOTHEEK DERIDDER do?

Trend over 20 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline